BANK OF AMERICA CORP /DE/
BankPosition in RVMD — Revolution Medicines, Inc.
CIK 70858
CHARLOTTE, NC
Position in RVMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$184,266,849
+$124,540,083 QoQ
Shares Held
983,911
+60.2% QoQ
Ownership
0.459%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 57%
Shared 0%
None 43%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Sep 30, 2023CallValue
$4,196,288
CallShares
151,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. RVMD ranks #10 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in RVMD
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $184,266,849 | 983,911 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $59,726,766 | 614,157 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $70,079,651 | 879,845 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $35,205,586 | 753,867 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $21,216,165 | 576,683 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,790,429 | 446,562 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $17,541,617 | 401,043 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $19,415,150 | 428,118 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,546,003 | 400,567 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $17,535,890 | 544,086 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,055,478 | 246,007 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,671,690 | 168,775 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $4,196,288 | 151,600 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $5,844,366 | 218,481 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $20,397,936 | 941,733 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $10,514,504 | 441,415 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $4,286,693 | 217,378 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,055,375 | 105,458 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,371,767 | 210,575 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $818,174 | 32,506 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $560,019 | 20,357 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $902,463 | 28,433 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $582,721 | 12,701 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $366,563 | 9,259 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $353,811 | 10,167 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $196,017 | 6,209 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $312,764 | 14,275 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||